🇺🇸 Pf-08032562 in United States

Pf-08032562 (pf-08032562) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pf-08032562 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Pf-08032562 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pf-08032562 in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.